SCHEMBL4674082

SCHEMBL4674082

COC(=O)CCc1ccc(OC(=S)N(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
HSD17B10 Q99714 1/20 0.51
F2RL1 P55085 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
PPARG P37231 1/20 0.42
ALOX5 P09917 1/20 0.42
EPHX2 P34913 1/20 0.41
POLB P06746 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091122 0.85 RAB9A (0.59) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL377282 0.85 LIPE (0.51) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL5747563 0.83 ACHE (0.52)
SCHEMBL10691629 0.81 MAPT (0.54) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL3920495 0.81 ALDH1A1 (0.43) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL22922181 0.79 CYP4F2 (0.59) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL1445627 0.77 F2RL1 (0.73) ALDH1A1MAPTLMNAHTTF2RL1
SCHEMBL8767622 0.77 KMT2A (0.66) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL5708212 0.76 ALDH1A1 (0.38) KMT2AALDH1A1MAPTLMNAHTT
SCHEMBL6540729 0.75 KDM4E (0.45) ALDH1A1LMNAHTTHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG KMT2A 2302/4885ALDH1A1 886/4885MAPT 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.